Number of the records: 1
Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects
Title Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects Author Sarapultsev Alexey P. Co-authors Vassiliev Pavel M. Grinchii Daniil 1979- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS Kiss Alexander SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV Mach Mojmír 1977- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV SCOPUS ORCID Osacká Jana 1980 SAVBIOMED ; SAVEXEND - Biomedicínske centrum SAV ORCID Ballóová Alexandra 1997- SAVEXFATO - Ústav experimentálnej farmakológie a toxikológie SAV Paliokha Ruslan 1996- SAVMOFYZ - Ústav molekulárnej fyziológie a genetiky SAV Kochetkov Andrey Sidorova Larisa Sarapultsev Petr A. Chupakhin Oleg N. Rantsev Maxim Spasov Alexander Dremencov Eliyahu 1973- SAVMOFYZ ; SAVEXEND - Ústav molekulárnej fyziológie a genetiky SAV SCOPUS ORCID Source document International Journal of Molecular Sciences. Vol. 22, no. 24 (2021), art. no. 13626 Language eng - English Country CH - Switzerland Document kind rozpis článkov z periodík (rbx) Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2021 Registered in WOS Registered in SCOPUS Registered in CCC DOI 10.3390/ijms222413626 
article
File name Access Size Downloaded Type License Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects.pdf available 2.9 MB 1 Publisher's version rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2021 2020 5.924 Q1 1.455 Q1
Number of the records: 1